Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 568
Filtrar
Más filtros

Medicinas Complementárias
Intervalo de año de publicación
1.
Med J Aust ; 218(7): 322-329, 2023 04 17.
Artículo en Inglés | MEDLINE | ID: mdl-36739106

RESUMEN

OBJECTIVES: To identify the financing and policy challenges for Medicare and universal health care in Australia, as well as opportunities for whole-of-system strengthening. STUDY DESIGN: Review of publications on Medicare, the Pharmaceutical Benefits Scheme, and the universal health care system in Australia published 1 January 2000 - 14 August 2021 that reported quantitative or qualitative research or data analyses, and of opinion articles, debates, commentaries, editorials, perspectives, and news reports on the Australian health care system published 1 January 2015 - 14 August 2021. Program-, intervention- or provider-specific articles, and publications regarding groups not fully covered by Medicare (eg, asylum seekers, prisoners) were excluded. DATA SOURCES: MEDLINE Complete, the Health Policy Reference Centre, and Global Health databases (all via EBSCO); the Analysis & Policy Observatory, the Australian Indigenous HealthInfoNet, the Australian Public Affairs Information Service, Google, Google Scholar, and the Organisation for Economic Co-operation and Development (OECD) websites. RESULTS: The problems covered by the 76 articles included in our review could be grouped under seven major themes: fragmentation of health care and lack of integrated health financing, access of Aboriginal and Torres Strait Islander people to health services and essential medications, reform proposals for the Pharmaceutical Benefits Scheme, the burden of out-of-pocket costs, inequity, public subsidies for private health insurance, and other challenges for the Australian universal health care system. CONCLUSIONS: A number of challenges threaten the sustainability and equity of the universal health care system in Australia. As the piecemeal reforms of the past twenty years have been inadequate for meeting these challenges, more effective, coordinated approaches are needed to improve and secure the universality of public health care in Australia.


Asunto(s)
Aborigenas Australianos e Isleños del Estrecho de Torres , Política de Salud , Servicios de Salud del Indígena , Programas Nacionales de Salud , Atención de Salud Universal , Anciano , Humanos , Australia , Servicios de Salud del Indígena/economía , Servicios de Salud del Indígena/normas , Programas Nacionales de Salud/economía , Programas Nacionales de Salud/normas , Política de Salud/economía
2.
In. Bermejo Bencomo, Walkiria. Control del cáncer en el embarazo y la infancia. La Habana, Editorial Ciencias Médicas, 2023. , tab.
Monografía en Español | CUMED | ID: cum-79243
3.
In. Bermejo Bencomo, Walkiria. Control del cáncer en el embarazo y la infancia. La Habana, Editorial Ciencias Médicas, 2023. , tab, ilus.
Monografía en Español | CUMED | ID: cum-79242
4.
In. Gray Lovio, Olaine Regla; Gómez Cabrera, Erasmo Pablo. Prevención, diagnóstico y tratamiento del cáncer de piel. La Habana, Editorial Ciencias Médicas, 2023. .
Monografía en Español | CUMED | ID: cum-79123
5.
In. Gray Lovio, Olaine Regla; Gómez Cabrera, Erasmo Pablo. Prevención, diagnóstico y tratamiento del cáncer de piel. La Habana, Editorial Ciencias Médicas, 2023. , tab.
Monografía en Español | CUMED | ID: cum-79122
6.
In. Gray Lovio, Olaine Regla; Gómez Cabrera, Erasmo Pablo. Prevención, diagnóstico y tratamiento del cáncer de piel. La Habana, Editorial Ciencias Médicas, 2023. , tab.
Monografía en Español | CUMED | ID: cum-79121
7.
Value Health ; 24(10): 1402-1406, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34593162

RESUMEN

This study aims to estimate the theoretical excess expenditure that would be incurred by the Irish state-payer, should drugs be reimbursed at their original asking ("list") price rather than at a price at which the drug is considered cost-effective. In Ireland, all new drugs are evaluated by the National Centre for Pharmacoeconomics. For this study, drugs that were submitted by pharmaceutical companies from 2012 to 2017 and considered not cost-effective at list price were reviewed. A total of 43 such drugs met our inclusion criteria, and their pharmacoeconomic evaluations were further assessed. The price at which the drug could be considered cost-effective (cost-effective price) at the upper cost-effectiveness threshold used in Ireland (€ 45 000/quality adjusted life-year) was estimated for 18 drugs with an available cost-effectiveness model. Then, for each drug, the list price and cost-effective price (both per unit) were both individually applied to 1 year of national real-world drug utilization data. This allowed the estimation of the expected expenditures under the assumptions of list price paid and cost-effective price paid. The resulting theoretical excess expenditure, the expenditure at list price minus the expenditure at the cost-effective price, was estimated to be €108.2 million. This estimate is theoretical because of the confidentiality of actual drug prices. The estimation is calculated using the list price and likely overestimates the actual excess expenditure, which would reduce to zero if cost-effective prices are agreed. Nevertheless, this estimate illustrates the importance of a process to assess the value of new drugs so that potential excess drug expenditure is identified.


Asunto(s)
Análisis Costo-Beneficio/métodos , Costos de la Atención en Salud/estadística & datos numéricos , Resultado del Tratamiento , Análisis Costo-Beneficio/estadística & datos numéricos , Utilización de Medicamentos/normas , Utilización de Medicamentos/estadística & datos numéricos , Costos de la Atención en Salud/normas , Humanos , Irlanda , Programas Nacionales de Salud/economía , Programas Nacionales de Salud/normas , Programas Nacionales de Salud/estadística & datos numéricos
8.
Future Oncol ; 17(25): 3331-3341, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-34156281

RESUMEN

Aim: To estimate current real-world costs of drugs and supportive care for the treatment of multiple myeloma in a tax-based health system. Methods: Forty-one patients were included from a personalized medicine study (2016-2019). Detailed information was collected from patient journals and hospital registries to estimate the total and mean costs using inverse probability weighting of censored data. Results: Total observed (censored) costs for the 41 patients was €8.84 million during 125 treatment years, with antineoplastic drugs as the main cost driver (€5.6 million). Individual costs showed large variations. Mean 3-year cost per patient from first progression was €182,103 (€131,800-232,405). Conclusion: Prediction of real-world costs is hindered by the availability of detailed costing data. Micro-costing analyses are needed for budgeting and real-world evaluation of cost-effectiveness.


Lay abstract In recent years, there has been a dramatic improvement in the treatment of multiple myeloma due to the introduction of new drugs. These drugs have significantly increased survival but have also had an immense impact on healthcare budgets. In this study, we used detailed treatment information for multiple myeloma patients in combination with billing data from the hospital pharmacy at a Danish hospital to calculate individual cost histories for both drugs and supportive care. Using these data, we estimated the mean 3-year cost of a multiple myeloma patient to be €182.103, but we also found large variation between patients, causing an uncertainty of €50.000 in either direction. We believe that detailed costing studies, similar to the present one, are necessary for evaluation of cost-effectiveness of drugs in clinical practice.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/economía , Costo de Enfermedad , Costos de la Atención en Salud/estadística & datos numéricos , Mieloma Múltiple/economía , Cuidados Paliativos/economía , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Análisis Costo-Beneficio/estadística & datos numéricos , Dinamarca/epidemiología , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Masculino , Oncología Médica/economía , Oncología Médica/normas , Oncología Médica/estadística & datos numéricos , Persona de Mediana Edad , Mieloma Múltiple/mortalidad , Mieloma Múltiple/terapia , Programas Nacionales de Salud/economía , Programas Nacionales de Salud/normas , Programas Nacionales de Salud/estadística & datos numéricos , Cuidados Paliativos/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Supervivencia sin Progresión , Sistema de Registros/estadística & datos numéricos , Factores de Tiempo
10.
Am J Trop Med Hyg ; 104(6): 2251-2263, 2021 04 12.
Artículo en Inglés | MEDLINE | ID: mdl-33844645

RESUMEN

According to the Kenya National School-Based Deworming program launched in 2012 and implemented for the first 5 years (2012-2017), the prevalence of soil-transmitted helminths (STH) and schistosomiasis substantially reduced over the mentioned period among the surveyed schools. However, this reduction is heterogeneous. In this study, we aimed to determine the factors associated with the 5-year school-level infection prevalence and relative reduction (RR) in prevalence in Kenya following the implementation of the program. Multiple variables related to treatment, water, sanitation, and hygiene (WASH) and environmental factors were assembled and included in mixed-effects linear regression models to identify key determinants of the school location STH and schistosomiasis prevalence and RR. Reduced prevalence of Ascaris lumbricoides was associated with low (< 1%) baseline prevalence, seven rounds of treatment, high (50-75%) self-reported coverage of household handwashing facility equipped with water and soap, high (20-25°C) land surface temperature, and community population density of 5-10 people per 100 m2. Reduced hookworm prevalence was associated with low (< 1%) baseline prevalence and the presence of a school feeding program. Reduced Trichuris trichiura prevalence was associated with low (< 1%) baseline prevalence. Reduced Schistosoma mansoni prevalence was associated with low (< 1%) baseline prevalence, three treatment rounds, and high (> 75%) reported coverage of a household improved water source. Reduced Schistosoma haematobium was associated with high aridity index. Analysis indicated that a combination of factors, including the number of treatment rounds, multiple related program interventions, community- and school-level WASH, and several environmental factors had a major influence on the school-level infection transmission and reduction.


Asunto(s)
Implementación de Plan de Salud/métodos , Helmintiasis/epidemiología , Higiene , Programas Nacionales de Salud/normas , Saneamiento , Esquistosomiasis/epidemiología , Suelo/parasitología , Agua , Animales , Estudios Transversales , Heces/parasitología , Implementación de Plan de Salud/normas , Implementación de Plan de Salud/estadística & datos numéricos , Helmintiasis/prevención & control , Helmintiasis/transmisión , Helmintos/clasificación , Helmintos/efectos de los fármacos , Humanos , Kenia/epidemiología , Modelos Estadísticos , Programas Nacionales de Salud/estadística & datos numéricos , Prevalencia , Análisis de Regresión , Esquistosomiasis/prevención & control , Esquistosomiasis/transmisión , Instituciones Académicas/estadística & datos numéricos
14.
Riv Psichiatr ; 55(6): 1-2, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33349715

RESUMEN

Scopo del presente lavoro è descrivere alcune reazioni umane e alcuni elementi di psicopatologia durante la pandemia. La pandemia ha messo in luce diversi aspetti dell'animo umano negli operatori sanitari, nei pazienti e nelle altre persone. Vi sono medici, infermieri, operatori che lavorano 24 ore su 24 per curare e assistere i malati, accompagnare chi non ce la fa. Incuranti del rischio di contagio, della fatica, dei propri bisogni hanno un'unica priorità : aiutare, fare il proprio dovere. Molti di loro si sono ammalati, molti sono morti. Tra loro vi è un alto tasso di contagiati, malati, qualcuno muore. Tutti sono stremati. Sono stati chiamati eroi, ma non tutti sono eroi. I nostri pazienti psichiatrici, inizialmente, sono i più adeguati, prudenti, saggi, responsabili. Con poche, semplici parole esprimono tanta consapevolezza e sana umanità. Al contrario, altre persone, quelle che normalmente si sentono "al di sopra delle cose", entrano nel panico Questa pandemia ci ha fatto capire (se ancora lo ignoravamo) che la vita è fragile, che tutto ciò che ci circonda e su cui costruiamo le nostre sicurezze è precario e incerto.


Asunto(s)
COVID-19/psicología , Miedo/psicología , Personal de Salud/psicología , Pandemias , Atención a la Salud , Humanos , Italia , Trastornos Mentales/psicología , Programas Nacionales de Salud/normas , Psicopatología , Xenofobia
15.
Pan Afr Med J ; 36: 340, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-33193993

RESUMEN

INTRODUCTION: globally, by 2020 the paralytic poliomyelitis disease burden decreased to over 99% of the reported cases in 1988 when resolution 41.8 was endorsed by the World Health Assembly (WHA) for global polio eradication. It is clearly understood that, if there is Wild Poliovirus (WPV) and circulating Vaccines Derived Poliovirus (cVDPV) in the world, no country is safe from polio outbreaks. All countries remain at high risk of re-importation depending on the level of the containment of the types vaccine withdrawn, the laboratory poliovirus isolates, and the population immunity induced by the vaccination program. In this regard, countries to have polio outbreak preparedness and response plans, and conducting the polio outbreak simulation exercises for these plans remain important. METHODS: we conducted a cross-section qualitative study to review to 8 countries conducted polio outbreak simulation exercises in the East and Southern Africa from 2016 to 2018. The findings were categorized into 5 outbreak response thematic areas analyzed qualitatively and summarized them on their strengths and weaknesses. RESULTS: we found out that, most countries have the overall technical capacities and expertise to deal with outbreaks to a certain extent. Nevertheless, we noted that the national polio outbreak preparedness and response plans were not comprehensive enough to provide proper guidance in responding to outbreaks. The guidelines were inadequately aligned with the WHO POSOPs, and IHR 2005. Additionally, most participants who participated in the simulation exercises were less familiar with their preparedness and response plans, the WHO POSOPs, and therefore reported to be sensitized. CONCLUSION: we also realized that, in all countries where the polio simulation exercise conducted, their national polio outbreak preparedness and response plan was revised to be improved in line with the WHO POSOPs and IHR 2005. we, therefore, recommend the polio outbreak simulation exercises to be done in every country with an interval of 3-5 years.


Asunto(s)
Defensa Civil/métodos , Poliomielitis/epidemiología , Poliomielitis/terapia , Entrenamiento Simulado/métodos , África del Sur del Sahara/epidemiología , Defensa Civil/organización & administración , Simulación por Computador , Estudios Transversales , Erradicación de la Enfermedad , Brotes de Enfermedades , Estudios de Evaluación como Asunto , Salud Global/normas , Implementación de Plan de Salud/organización & administración , Implementación de Plan de Salud/normas , Historia del Siglo XXI , Humanos , Programas de Inmunización/métodos , Programas de Inmunización/organización & administración , Programas de Inmunización/normas , Programas Nacionales de Salud/organización & administración , Programas Nacionales de Salud/normas , Vacunas contra Poliovirus/provisión & distribución , Vacunas contra Poliovirus/uso terapéutico , Vigilancia de la Población , Estudios Retrospectivos , Medición de Riesgo , Entrenamiento Simulado/organización & administración , Entrenamiento Simulado/normas , Reserva Estratégica/métodos , Reserva Estratégica/organización & administración
17.
Adv Respir Med ; 88(4): 297-304, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32869262

RESUMEN

INTRODUCTION: The "Maps of Health Needs" project has been carried out in Poland since 2016 and its purpose is to implement quality-promoting and organisational solutions in the Polish healthcare system. This paper is the analysis of hospitalisations for chronic respiratory diseases recorded in Polish National Health Fund databases in 2014. MATERIAL AND METHODS: The study included 122,000 hospitalisations of adults and 22,000 hospitalisations of children. Epidemio-logical parameters (incidence and prevalence) and major hospitalisation parameters were determined through statistical analysis. RESULTS: The highest registered incidence was observed in asthma patients (548 per 100,000 inhabitants) followed by COPD patients (233 per 100,000 inhabitants). Asthma patients were also characterised by the highest prevalence, with lower values being observed in COPD patients. In the group of adults, patients aged 65 years or older and 80 years or older accounted for 44% and 14% of hospitalised adults respectively. The analysis also revealed that 66% of hospitalisations of adults included patients with asthma, COPD and respiratory failure. The development of respiratory failure prolongs hospitalisation and increases both in-hospital and post-discharge mortality. In children, 90% of the identified hospitalisations were for asthma, chronic inflammatory lung diseases and cystic fibrosis. CONCLUSIONS: The results of the study demonstrate that pulmonary obstructive diseases are associated with a considerable burden. Therefore, corrective actions within the Polish healthcare system are required to decrease the number of hospitalisations for these diseases.


Asunto(s)
Hospitalización/estadística & datos numéricos , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Enfermedad Pulmonar Obstructiva Crónica/terapia , Adolescente , Adulto , Anciano , Niño , Preescolar , Femenino , Humanos , Persona de Mediana Edad , Programas Nacionales de Salud/normas , Alta del Paciente/estadística & datos numéricos , Polonia , Prevalencia , Neumología/normas , Factores de Riesgo
18.
Hum Reprod Update ; 26(6): 886-903, 2020 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-32712660

RESUMEN

BACKGROUND: Induced abortion is a common procedure. However, there is marked variation in accessibility of services across England. Accessing abortion services may be difficult, particularly for women who live in remote areas, are in the second trimester of pregnancy, have complex pre-existing conditions or have difficult social circumstances. OBJECTIVE AND RATIONALE: This article presents a two-part review undertaken for a new National Institute of Health and Care Excellence guideline on abortion care, and aiming to determine: the factors that help or hinder accessibility and sustainability of abortion services in England (qualitative review), and strategies that improve these factors, and/or other factors identified by stakeholders (quantitative review). Economic modelling was undertaken to estimate cost savings associated with reducing waiting times. SEARCH METHODS: Ovid Embase Classic and Embase, Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R), PsycINFO, Cochrane Library via Wiley Online, Cinahl Plus and Web of Science Core Collection were searched for articles published up to November 2018. Studies were included if they were published in English after 2001, conducted in Organization for Economic Co-operation and Development (OECD) countries and were: qualitative studies reporting views of patients and/or staff on factors that help or hinder the accessibility and sustainability of a safe abortion service, or randomized or non-randomized studies that compared strategies to improve factors identified by the qualitative review and/or stakeholders. Studies were excluded if they were conducted in OECD countries where abortion is prohibited altogether or only performed to save the woman's life. One author assessed risk of bias of included studies using the following checklists: Critical Appraisal Skills Programme checklist for qualitative studies, Cochrane Collaboration quality checklist for randomized controlled trials, Newcastle-Ottawa scale for cohort studies, and Effective Practice and Organization of Care risk of bias tool for before-and-after studies.Qualitative evidence was combined using thematic analysis and overall quality of the evidence was assessed using Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Confidence in the Evidence from Reviews of Qualitative Research (CERQual). Quantitative evidence was analysed in Review Manager 5.3 and overall quality of evidence was assessed using GRADE. OUTCOMES: Eight themes (service level barriers; financial barriers; logistical barriers; personal barriers; legal and policy barriers; privacy and confidentiality concerns; training and education; community prescribing and telemedicine introduce greater flexibility) and 18 subthemes were identified from 23 papers (n = 1016) included in the qualitative review. The quality of evidence ranged from very low to high, with evidence for one theme and seven subthemes rated as high quality. Nine studies (n = 7061) were included in the quantitative review which showed that satisfaction was better (low to high quality evidence) and women were seen sooner (very low quality evidence) when care was led by nurses or midwives compared with physician-led services, women were seen sooner when they could self-refer (very low quality evidence), and clinicians were more likely to provide abortions if training used an opt-out model (very low quality evidence). Economic modelling showed that even small reductions in waiting times could result in large cost savings for services. WIDER IMPLICATIONS: Self-referral, funding for travel and accommodation, reducing waiting times, remote assessment, community services, maximizing the role of nurses and midwives and including practical experience of performing abortion in core curriculums, unless the trainee opts out, should improve access to and sustainability of abortion services.


Asunto(s)
Aborto Inducido , Accesibilidad a los Servicios de Salud , Guías de Práctica Clínica como Asunto , Aborto Inducido/normas , Aborto Inducido/estadística & datos numéricos , Adolescente , Adulto , Inglaterra/epidemiología , Femenino , Adhesión a Directriz/organización & administración , Adhesión a Directriz/normas , Adhesión a Directriz/estadística & datos numéricos , Accesibilidad a los Servicios de Salud/organización & administración , Accesibilidad a los Servicios de Salud/normas , Accesibilidad a los Servicios de Salud/estadística & datos numéricos , Humanos , Programas Nacionales de Salud/organización & administración , Programas Nacionales de Salud/normas , Programas Nacionales de Salud/estadística & datos numéricos , Embarazo , Investigación Cualitativa , Adulto Joven
19.
Euro Surveill ; 25(25)2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32613939

RESUMEN

Sentinel surveillance of acute hospitalisations in response to infectious disease emergencies such as the 2009 influenza A(H1N1)pdm09 pandemic is well described, but recognition of its potential to supplement routine public health surveillance and provide scalability for emergency responses has been limited. We summarise the achievements of two national paediatric hospital surveillance networks relevant to vaccine programmes and emerging infectious diseases in Canada (Canadian Immunization Monitoring Program Active; IMPACT from 1991) and Australia (Paediatric Active Enhanced Disease Surveillance; PAEDS from 2007) and discuss opportunities and challenges in applying their model to other contexts. Both networks were established to enhance capacity to measure vaccine preventable disease burden, vaccine programme impact, and safety, with their scope occasionally being increased with emerging infectious diseases' surveillance. Their active surveillance has increased data accuracy and utility for syndromic conditions (e.g. encephalitis), pathogen-specific diseases (e.g. pertussis, rotavirus, influenza), and adverse events following immunisation (e.g. febrile seizure), enabled correlation of biological specimens with clinical context and supported responses to emerging infections (e.g. pandemic influenza, parechovirus, COVID-19). The demonstrated long-term value of continuous, rather than incident-related, operation of these networks in strengthening routine surveillance, bridging research gaps, and providing scalable public health response, supports their applicability to other countries.


Asunto(s)
Hospitales Pediátricos/estadística & datos numéricos , Programas de Inmunización/normas , Admisión del Paciente/estadística & datos numéricos , Vigilancia de la Población/métodos , Vacunación/efectos adversos , Vacunas/administración & dosificación , Australia/epidemiología , Canadá/epidemiología , Niño , Preescolar , Exactitud de los Datos , Política de Salud , Hospitalización/estadística & datos numéricos , Humanos , Programas Nacionales de Salud/normas , Vigilancia en Salud Pública , Vacunación/estadística & datos numéricos
20.
PLoS One ; 15(6): e0234874, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32574200

RESUMEN

BACKGROUND: It is estimated that millions of patients are affected by healthcare associated infections (HAIs) each year. In Ghana, high prevalence of HAIs in relation to non-surgical (also called contaminated wounds) and surgical wounds (also called sterile wounds) is largely attributed to poor adherence to policy protocols for wound management by frontline clinical staff especially nurses. OBJECTIVE: Investigate the extent to which nursing staff adhere to the policy protocol for management of non-surgical and surgical wounds in selected public health facilities in Ghana. METHODOLOGY: This is an analytic case study among nursing staff (n = 140) in three government facilities in the Volta region of Ghana. Subjective and objective performance scores of staff on adherence proxies were compared using the Wilcoxon Signed-rank test, and univariate ordered logistic regression analysis used to predict staff likelihood of adherence to policy protocols on non-surgical and surgical wound management. FINDINGS: Overall, staff self-rated themselves higher on subjective performance proxies relative to their objective scores (p<0.05). Staff with more years of work experience did not translate into a higher likelihood of adhering to standard protocol on wound management (Coef. = -0.49, CI = -0.93-0.05, p = 0.036). Being a senior nursing officer relative to lower nursing ranks increased staff likelihood of complying particularly with standard policy protocol for management of non-surgical wounds (Coef. 5.27, CI = 0.59 9.95, p = 0.027). CONCLUSION: There is the need for accelerated in-service training for staff on standard protocols for wound management coupled with supportive supervisions. Staff adherence to standard quality care protocols should be a pre-requisite for licensing of health facilities by regulatory bodies like Health Facilities Regulatory Agency and National Health Insurance Authority.


Asunto(s)
Infección Hospitalaria/terapia , Implementación de Plan de Salud , Hospitales Públicos/organización & administración , Personal de Enfermería/organización & administración , Heridas y Lesiones/terapia , Adulto , Protocolos Clínicos/normas , Infección Hospitalaria/epidemiología , Femenino , Ghana/epidemiología , Adhesión a Directriz , Política de Salud , Humanos , Masculino , Programas Nacionales de Salud/normas , Personal de Enfermería/normas , Personal de Enfermería/estadística & datos numéricos , Prevalencia , Calidad de la Atención de Salud , Encuestas y Cuestionarios/estadística & datos numéricos , Heridas y Lesiones/epidemiología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA